Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation

Circulation

Volumn 100, Issue 20, 1999, Pages 2067-2073

  Holmes Jr , David R ^a   Berger, Peter B ^a   Hochman, Judith S ^b   Granger, Christopher B ^c   Thompson, Trevor D ^d   Califf, Robert M ^c   Vahanian, Alec ^e   Bates, Eric R ^f   Topol, Eric J ^g  

^a MAYO CLINIC   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d EMORY UNIVERSITY   (United States)

^e HÔPITAL TENON   (France)

^f UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acute coronary syndromes; Mortality; Myocardial infarction; Shock; Unstable angina

Indexed keywords

CREATINE KINASE; HEPARIN; HIRUDIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

EID: 0345201633     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.20.2067     Document Type: Article

References (29)

1. Goldberg RJ, Gore JM, Alpert JS, Osganian V, deGroot J, Bade J, Chen A, Frid D, Dalen JE. Cardiogenic shock after acute myocardial infarction: incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med. 1991;325:1117-1122.
2. Bengtson JR, Kaplan AJ, Pieper KS, Wildermann NM, Mark DB, Pryor DB, Phillips HR, Califf RM. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol. 1992; 20:1482-1489.
3. Holmes DR Jr, Bates ER, Kleiman NS, Sadowski Z, Horgan JH, Morris DC, Califf RM, Berger PB, Topol EJ, for the GUSTO-I Investigators. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. J Am Coll Cardiol. 1995;26:668-674.
4. Hasdai D, Holmes DR Jr, Califf RM, Thompson TD, Hochman JS, Pfisterer M, Topol EJ, for the GUSTO-I Investigators. Cardiogenic shock complicating acute myocardial infarction: predictors of mortality. Am Heart J. 1999;138:21-31.
5. Berger PB, Tuttle RH, Holmes DR Jr, Topol EJ, Aylward PE, Horgan JH, Califf RM. One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: results from the GUSTO-I trial. Circulation. 1999;99-873-878.
6. Mueller HS. Role of intra-aortic counterpulsation in cardiogenic shock and acute myocardial infarction. Cardiology. 1996;84:168-174.
7. Subramanian VA, Roberts AJ, Zema MJ, Abel RM, McCabe JC, Hoover E, Kligfield P, Gay WA. Cardiogenic shock following acute myocardial infarction: late functional results after emergency cardiac surgery. N Y State J Med. 1980;80:947-952.
8. Waksman R, Weiss AT, Gotsman MS, Hasin Y. Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction. Eur Heart J. 1993;14:71-74.
9. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996;335: 775-782.
10. Dole WP, O'Rourke RA. Pathophysiology and management of cardiogenic shock. Curr Probl Cardiol. 1983;8:1-72.
11. Gheorghiade M, Anderson J, Rosman H. Risk identification at the time of admission to coronary care unit in patients with suspected myocardial infarction. Am Heart J. 1988;116:1212-1217.
12. Scheldt S, Ascheim R, Killip T. Shock alter acute myocardial infarction: a clinical and hemodynamic profile. Am J Cardiol. 1970;26:556-564.
13. Col NF, Gurentz JH, Alpert JS, Goldberg RJ. Frequency of inclusion of patients with cardiogenic shock in trial of thrombolytic therapy. Am J Cardiol. 1994;73:149-157.
14. Nicod P, Gilpin E, Dittrich H, Polikar R, Hjalmarson A, Blacky AR, Henning H, Ross J Jr. Short- and long-term clinical outcome after Q-wave and non-Q-wave myocardial infarction in a large patient population. Circulation. 1989;79:528-536.
15. Cohen M, Hawkins L, Greenberg S, Fuster V. Usefulness of ST-segment changes in ≥2 leads on the emergency room electrocardiogram in either unstable angina pectoris or non-Q-wave myocardial infarction in predicting outcome. Am J Cardiol. 1991;67:1368-1373.
16. Stark ME, Vacek JL. The initial electrocardiogram during admission for myocardial infarction. Arch Intern Med. 1987;147:843-846.
17. Slater DK, Hlatky MA, Mark DB, Harrell FE, Pryor DB, Califf RM. Outcome in suspected acute myocardial infarction with normal or minimally abnormal admission electrocardiographic findings. Am J Cardiol 1987;60:766-770.
18. Rouan GW, Lee TH, Cook EF, Brand DA, Weisberg MC, Goldman L. Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms: report from the Multicenter Chest Pain Study. Am J Cardiol. 1989-64-1087-1092.
19. Shiang Lee H, Cross SJ, Rawles JM, Jennings KP. Patients with suspected myocardial infarction who present with ST depression Lancet 1993;345:1204-1207.
20. Haines DE, Raabe DS, Gundel WD, Wackers FJT. Anatomic and prognostic significance of new T-wave inversion in unstable angina. Am J Cardiol. 1983;52:14-18.
21. Granborg J, Grande P, Pedersen A. Diagnostic and prognostic implications of transient isolated negative T-waves in suspected acute myocardial infarction. Am J Cardiol. 1986;57:203-207.
22. Hochman JS, Boland J, Sleeper LA, Porway M, Brinker J, Col J, Jacobs A, Slater J, Miller D, Wasserman H, Menegus MA, Talley JD, McKinlay S, Sanbora T, LeJemtel T, for the SHOCK Registry Investigators. Current spectrum of cardiogenic shock and effect of early revascularization on mortality: results of an international registry. Circulation 1995-91: 873-881.
23. GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673-682.
24. White HD, Barbash GI, Califf RM, Simes RJ, Granger CB, Weaver WD, Kleiman NS, Aylward PE, Gore JM, Vahanian A, Lee KL, Ross AM, Topol EJ. Age and outcome with contemporary thrombolytic therapy: results from the GUSTO-I trial. Circulation. 1996;94:1826-1833.
25. Aylward PE, Wilcox RG, Horgan JH, White HD, Granger CB, Califf RM, Topol EJ, for the GUSTO-I Investigators. Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. Ann Intern Med. 1996;125:891-900.
26. GISSI Investigators. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;2:397-401.
27. ISIS-2 Investigators. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. J Am Coll Cardiol. 1988;12:3A-13A.
28. Shah M, Kong DF, Al-Khatib S, Hudson MP, Greenbaum AB, Cantor W, Alexander JH. Highlights from the American College of Cardiology Scientific Sessions. Am Heart J. 1999;138:175-190.
29. Holmes DR Jr, Califf RM, Van de Werf F, Berger PB, Bates ER, Simoons ML, White HD, Thompson TD, Topol EJ, for the GUSTO-I investigators. Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet. 1997;349:75-78.